Ameritas Advisory Services, LLC Edwards Lifesciences Corp Transaction History

Ameritas Advisory Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $237,133 - $312,385	3,269 New	3,269 $312,000
Q1 2023 Apr 28, 2023	SELL	$74.26 - $84.51 $148,371 - $168,850	-1,998 Reduced 41.95%	2,765 $228,000
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $133,048 - $170,333	1,948 Added 69.2%	4,763 $355,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $3,212 - $4,184	39 Added 1.4%	2,815 $233,000
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $2,595 - $3,848	-30 Reduced 1.07%	2,776 $264,000
Q1 2022 May 04, 2022	SELL	$101.96 - $128.34 $25,184 - $31,699	-247 Reduced 8.09%	2,806 $330,000
Q4 2021 Feb 07, 2022	BUY	$106.37 - $130.68 $324,747 - $398,966	3,053 New	3,053 $395,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Ameritas Advisory Services, LLC with notifications on news.